¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"immun"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • immunoregulation
    ¸é¿ªÁ¶Àý
  • immunoregulatory
    ¸é¿ªÁ¶Àý-
  • immunorejection
    ¸é¿ª°ÅºÎ¹ÝÀÀ
  • immunoselection
    ¸é¿ª¼±ÅÃ
  • immunostimulant
    1. ¸é¿ªÀÚ±Ø- 2. ¸é¿ªÀÚ±ØÁ¦
  • immunostimulation
    ¸é¿ªÀÚ±Ø
  • immunostimulator
    ¸é¿ªÀÚ±ØÁ¦
  • immunosuppressant
    ¸é¿ª¾ïÁ¦Á¦
  • immunosuppression
    ¸é¿ª¾ïÁ¦
  • immunosuppressive
    1. ¸é¿ª¾ïÁ¦- 2. ¸é¿ª¾ïÁ¦Á¦
  • immunosuppressive therapy
    ¸é¿ª¾ïÁ¦¿ä¹ý
  • immunosurveillance
    ¸é¿ª°¨½Ã
  • immunotherapy
    ¸é¿ª¿ä¹ý
  • immunotoxin
    ¸é¿ªµ¶¼Ò
  • immunotransfusion
    ¸é¿ª¼öÇ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 9 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • immunostimulation
    ¸é¿ªÀÚ±Ø
  • immunostimulator
    ¸é¿ªÀÚ±ØÁ¦
  • immunosuppressant
    ¸é¿ª¾ïÁ¦Á¦
  • immunosuppression
    ¸é¿ª¾ïÁ¦
  • immunosuppressive therapy
    ¸é¿ª¾ïÁ¦¿ä¹ý
  • immunosurveillance
    ¸é¿ª°¨½Ã
  • immunotherapy
    ¸é¿ª¿ä¹ý
  • immunotoxin
    ¸é¿ªµ¶¼Ò
  • immunotransfusion
    ¸é¿ª¼öÇ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • immunoelectrophoresis
    ¸é¿ªÀü±â¿µµ¿¹ý
  • immunoelectrophoresis Western blot test
    ¸é¿ªÀü±â¿µµ¿ ¿þ½ºÅϺí·ÎÆ®½ÃÇè
  • immunoelectrophoresis, counter current
    ¿ª¸é¿ªÀü±â¿µµ¿¹ý
  • immunoelectrophoresis, crossed
    ±³Â÷¸é¿ªÀü±â¿µµ¿¹ý
  • immunoelectrophoresis, rocket
    ·ÎÄÉÆ®¸ð¾ç ¸é¿ªÀü±â¿µµ¿
  • immunoenzyme technique
    ¸é¿ªÈ¿¼Ò¹ý
  • immunoenzymometric assay
    ¸é¿ªÈ¿¼Ò°èÃø<--°è·®>ºÐ¼®
  • immunofacilitation
    ¸é¿ªÃËÁø.
  • immunoferritin technique
    ¸é¿ªÆä¸®Æ¾¹ý
  • immunofixation
    ¸é¿ª°íÁ¤
  • immunofixation analysis
    ¸é¿ª°íÁ¤ºÐ¼®
  • immunofluorescence
    ¸é¿ªÇü±¤(°Ë»ç¹ý).
  • immunofluorescence assay
    ¸é¿ªÇü±¤°Ë»ç
  • immunofluorescence band test
    ¸é¿ª Çü±¤´ë°Ë»ç
  • immunofluorescence microscopy
    ¸é¿ªÇü±¤Çö¹Ì°æ(°Ë»ç)¹ý.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • immunodeficiency syndrome, severe combined
    ÁßÁõº¹ÇÕÇü ¸é¿ª°áÇÌ ÁõÈıº
  • immunodeficient
    ¸é¿ª°áÇÌÀÇ
  • immunodeviation
    ¸é¿ªÆíÇâ, ¸é¿ªÆí±â, ¸é¿ªÀÏÅ».
  • immunodiagnosis
    ¸é¿ªÁø´Ü.
  • immunodiagnostic method
    ¸é¿ªÁø´Ü(¹æ)¹ý
  • immunodiffusion
    ¸é¿ªÈ®»ê(¹ý)
  • immunodiffusion
    ¸é¿ªÈ®»ê(¹ý).
  • immunodominance
    °í¸é¿ª¿ø¼º
  • immunodominant
    ¸é¿ªÁö¹èÀû.
  • immunoelectrophoresis
    ¸é¿ªÀü±â¿µµ¿(¹ý).
  • immunoelectrophoresis
    ¸é¿ªÀü±â¿µµ¿¹ý
  • immunoelectrophoresis
    ¸é¿ªÀü±â¿µµ¿¹ý.
  • immunoelectrophoresis Western blot test
    ¸é¿ªÀü±â¿µµ¿ ¿þ½ºÅϺí·ÎÆ®½ÃÇè
  • immunoelectrophoresis, counter current
    ¿ª¸é¿ªÀü±â¿µµ¿¹ý
  • immunoelectrophoresis, crossed
    ±³Â÷¸é¿ªÀü±â¿µµ¿¹ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
immunoglobulin isotypes The classes of immunoglobulins found in any species of animal. In man there are nine classes that migrate in five different groups in electrophoresis; they each consist of two light and two heavy protein chains, and each group has distinguishing structural and functional properties.
(12 Dec 1998)
immunoglobulin joining region Segment of light and heavy chains of mouse and human immunoglobulins where the genes for the variable region upstream join those of the constant region downstream (an important part of the antibody diversity mechanism). In the joining region of the light chain are the genes coding for amino acids 96 to 107.
(12 Dec 1998)
immunoglobulin M <immunology> An immunoglobulin M molecule (970 kD) is built up from five immunoglobulin G type monomers joined together, with the assistance of J chains, to form a cyclic pentamer.
Immunoglobulin M binds complement and a single molecule bound to a cell surface can lyse that cell. Immunoglobulin M is usually produced first in an immune response before immunoglobulin G.
The human red cell isoantibodies are immunoglobulin M antibodies. Heavy chain (mu chain) is rather larger than the heavy chains of other immunoglobulins.
(30 Mar 1998)
immunoglobulin superfamily <immunology> A large group of proteins with immunoglobulin like domains. most are involved with cell surface recognition events.
Sequence homologyy suggests that immunoglobulins, MHC molecules, some cell adhesion molecules and cytokines receptors share close homology and thus belong to a multigene family.
(30 Mar 1998)
immunoglobulin switch region Site on a segment of a B-cell immunoglobulin heavy-chain gene where recombination or rearrangement can occur, expressed as isotype or allotype switching, maturation of immune response, or recombination of DNA molecules. It is found on genes encoding all five immunoglobulin heavy chains.
(12 Dec 1998)
immunoglobulin variable region That region of the immunoglobulin (antibody) molecule that varies in its amino acid sequence and composition, confers the antigenic specificity, and is thought to comprise the binding site for the antigen. It is located at the n-terminus of the fab fragment of the immunoglobulin. It includes hypervariable and framework regions, vh family subgroups, and the complementarity-determining region.
(12 Dec 1998)
immunoglobulins Any of the structurally related glycoproteins that function as antibodies. They are divided into five classes (IgA, IgD, IgE, IgG, IgM) on the basis of structure and biological activity.
(12 Dec 1998)
immunoglobulins, alpha-chain Heavy chains found in the fab and fc fragments of IgA and having a molecular weight of approximately 58 kD. They contain about 470 amino acid residues arranged in four domains and an oligosaccharide component bound covalently to the fc fragment.
(12 Dec 1998)
immunoglobulins, delta-chain Heavy chains found in the fab and fc fragments of IgD and having a molecular weight of approximately 64 kD. They contain about 500 amino acid residues arranged in four domains and an oligosaccharide component covalently bound to the fc fragment.
(12 Dec 1998)
immunoglobulins, epsilon-chain Heavy chains found in the fab and fc fragments of IgE and having a molecular weight of approximately 72 kD. They contain about 550 amino acid residues arranged in five domains and about three times more carbohydrate than the heavy chains of IgA, IgD, and IgG.
(12 Dec 1998)
immunoglobulins, fab Antigen-binding fragments composed of one entire light chain and about half of one of the heavy chains, linked to each other by disulfide bonds. Fab contains the antigen binding site which is part of the variable region of the immunoglobulin molecule.
(12 Dec 1998)
immunoglobulins, fc Crystallizable fragments composed of the carboxy-terminal halves of both heavy chains linked to each other by disulfide bonds. Fc fragments are responsible for the effector functions of antibodies (complement fixation, binding to cell membranes, and placental transport).
(12 Dec 1998)
immunoglobulins, gamma-chain Heavy chains found in the fab and fc fragments of IgG and having a molecular weight of approximately 51 kD. They contain about 450 amino acid residues arranged in four domains and an oligosaccharide component covalently bound to the fc fragment. The gamma chains of the four IgG subgroups are not identical, but resemble each other more closely than the heavy chains of a different immunoglobulin.
(12 Dec 1998)
immunoglobulins, heavy-chain Major components of immunoglobulin molecules. They are the larger of the two types of polypeptide chains responsible for the biological and immunological properties of the different immunoglobulins. They differ according to the class of ig from which they were isolated, contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kD. One ig molecule comprises two heavy and two light chains.
(12 Dec 1998)
immunoglobulins, intravenous Immunoglobulin preparations used in intravenous infusion, containing primarily IgG. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including paediatric aids, primary hypergammaglobulinaemia, scid, cytomegalovirus infections in transplant recipients, chronic lymphocytic leukaemia, kawasaki syndrome, infection in neonates, and idiopathic thrombocytopenic purpura.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 11
  • Immunoglobulin Heavy Chains - »õâ The largest of polypeptide chains comprising immunoglobulins. They contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kDa.
    Synonyms : Heavy-Chain Immunoglobulins, Ig Heavy Chains, Immunoglobulin Heavy Chain, Immunoglobulin Heavy Chain Subgroup VH-I, Immunoglobulin Heavy Chain Subgroup VH-III, Heavy Chain Immunoglobulins, Heavy Chain, Immunoglobulin, Heavy Chains, Ig
  • Immunoglobulin Idiotypes - »õâ Unique, genetically controlled determinants present on ANTIBODIES whose specificity is limited to a single group of proteins (e.g., another antibody molecule or an individual myeloma protein). The idiotype appears to represent the antigenicity of the antigen-binding site of the antibody and to be genetically codetermined with it. The idiotypic determinants have been precisely located to the IMMUNOGLOBULIN VARIABLE REGION of both immunoglobin polypeptide chains.
    Synonyms : Idiotype, Immunoglobulin, Immunoglobulin Idiotype
  • Immunoglobulin Isotypes - »õâ The classes of immunoglobulins found in any species of animal. In man there are nine classes that migrate in five different groups in electrophoresis; they each consist of two light and two heavy protein chains, and each group has distinguishing structural and functional properties.
    Synonyms : Antibody Classes, Immunoglobulin Classes, Classes, Antibody, Classes, Immunoglobulin, Isotypes, Immunoglobulin
  • Immunoglobulin J Recombination Signal Sequence-Binding Protein - »õâ A ubiquitously expressed sequence-specific transcriptional repressor that is normally the target of signaling by NOTCH PROTEINS.
    Synonyms : C-Promotor-Binding Factor 1, RBP-Jkappa Protein, Recombination Binding Protein J, C Promotor Binding Factor 1, Immunoglobulin J Recombination Signal Sequence Binding Protein, RBP Jkappa Protein
  • Immunoglobulin J-Chains - »õâ A 15 kD "joining" peptide that forms one of the linkages between monomers of IMMUNOGLOBULIN A or IMMUNOGLOBULIN M in the formation of polymeric immunoglobulins. There is one J chain per one IgA dimer or one IgM pentamer. It is also involved in binding the polymeric immunoglobulins to POLYMERIC IMMUNOGLOBULIN RECEPTOR which is necessary for their transcytosis to the lumen. It is distinguished from the IMMUNOGLOBULIN JOINING REGION which is part of the IMMUNOGLOBULIN VARIABLE REGION of the immunoglobulin light and heavy chains.
    Synonyms : Ig J-Peptide, Immunoglobulin J Polypeptide, Immunoglobulin J-Peptide, Ig J Peptide, Immunoglobulin J Chains, Immunoglobulin J Peptide, J Chains, Immunoglobulin, J Polypeptide, Immunoglobulin, J-Peptide, Ig, J-Peptide, Immunoglobulin
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
immunosuppression Suppression of the body's immune system and its ability to fight infections or disease. Immunosuppression may be deliberately induced with drugs, as in preparation for bone marrow or other organ transplantation to prevent rejection of the donor tissue. It may also result from certain diseases such as AIDS or lymphoma or from anticancer drugs.
Ãâó: www.stjude.org/glossary
immunization A technique used to cause an immune response that results in resistance to a specific disease, especially an infectious disease.
Ãâó: www.stjude.org/glossary
immunoassay A test that uses the binding of antibodies to antigens to identify and measure certain substances. Immunoassays may be used to diagnose disease. Also, test results can provide information about a disease that may help in planning treatment (for example, when estrogen receptors are measured in breast cancer).
Ãâó: www.stjude.org/glossary
immunocompetence The ability to produce a normal immune response.
Ãâó: www.stjude.org/glossary
immunocompromised Having a weakened immune system caused by certain diseases or treatments.
Ãâó: www.stjude.org/glossary
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 11
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
ÅëÇÕ°Ë»ö ¿Ï·á